Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Scott Patterson, Jacob George, Simone Strasser, Alice Lee, William Sievert, Amanda Nicoll, Paul Desmond, Stuart Roberts, Stephen Locarnini, Scott Bowden, Peter Angus

Research output: Contribution to journalArticleResearchpeer-review

145 Citations (Scopus)


To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).
Original languageEnglish
Pages (from-to)247 - 254
Number of pages8
Issue number2
Publication statusPublished - 2011

Cite this